163 related articles for article (PubMed ID: 25619199)
1. Characterization of solid lipid nanoparticles containing caffeic acid and determination of its effects on MCF-7 cells.
Dikmen G; Guney G; Genc L
Recent Pat Anticancer Drug Discov; 2015; 10(2):224-32. PubMed ID: 25619199
[TBL] [Abstract][Full Text] [Related]
2. Emodin loaded solid lipid nanoparticles: preparation, characterization and antitumor activity studies.
Wang S; Chen T; Chen R; Hu Y; Chen M; Wang Y
Int J Pharm; 2012 Jul; 430(1-2):238-46. PubMed ID: 22465546
[TBL] [Abstract][Full Text] [Related]
3. Novel resveratrol smart lipids; design, formulation, and biological evaluation of anticancer activity.
Diab RF; Abdelghany TM; Gad S; Elbakry AM
J Pharm Pharmacol; 2024 Jun; 76(6):631-645. PubMed ID: 38507715
[TBL] [Abstract][Full Text] [Related]
4. Preparation, optimization, and
Nasiri F; Faghfouri L; Hamidi M
Drug Dev Ind Pharm; 2020 Jan; 46(1):159-171. PubMed ID: 31894713
[No Abstract] [Full Text] [Related]
5. Synthesis, characterization, and kinetic release study of methotrexate loaded mPEG-PCL polymersomes for inhibition of MCF-7 breast cancer cell line.
Nosrati H; Adinehvand R; Manjili HK; Rostamizadeh K; Danafar H
Pharm Dev Technol; 2019 Jan; 24(1):89-98. PubMed ID: 29307260
[TBL] [Abstract][Full Text] [Related]
6. Solid lipid nanoparticles: Reversal of tamoxifen resistance in breast cancer.
Guney Eskiler G; Cecener G; Dikmen G; Egeli U; Tunca B
Eur J Pharm Sci; 2018 Jul; 120():73-88. PubMed ID: 29719240
[TBL] [Abstract][Full Text] [Related]
7. Development of Curcumin-Loaded Solid Lipid Nanoparticles Utilizing Glyceryl Monostearate as Single Lipid Using QbD Approach: Characterization and Evaluation of Anticancer Activity Against Human Breast Cancer Cell Line.
Bhatt H; Rompicharla SVK; Komanduri N; Aashma S; Paradkar S; Ghosh B; Biswas S
Curr Drug Deliv; 2018; 15(9):1271-1283. PubMed ID: 29732970
[TBL] [Abstract][Full Text] [Related]
8. Naringenin-loaded solid lipid nanoparticles: preparation, controlled delivery, cellular uptake, and pulmonary pharmacokinetics.
Ji P; Yu T; Liu Y; Jiang J; Xu J; Zhao Y; Hao Y; Qiu Y; Zhao W; Wu C
Drug Des Devel Ther; 2016; 10():911-25. PubMed ID: 27041995
[TBL] [Abstract][Full Text] [Related]
9. Solid lipid nanoparticles for the controlled delivery of poorly water soluble non-steroidal anti-inflammatory drugs.
Kumar R; Singh A; Garg N; Siril PF
Ultrason Sonochem; 2018 Jan; 40(Pt A):686-696. PubMed ID: 28946474
[TBL] [Abstract][Full Text] [Related]
10. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?
Das S; Ng WK; Tan RB
Eur J Pharm Sci; 2012 Aug; 47(1):139-51. PubMed ID: 22664358
[TBL] [Abstract][Full Text] [Related]
11. New Folate-Modified Human Serum Albumin Conjugated to Cationic Lipid Carriers for Dual Targeting of Mitoxantrone against Breast Cancer.
Ridha AA; Kashanian S; Azandaryani AH; Rafipour R; Mahdavian E
Curr Pharm Biotechnol; 2020; 21(4):305-315. PubMed ID: 31729941
[TBL] [Abstract][Full Text] [Related]
12. Delivery of retinoic acid to LNCap human prostate cancer cells using solid lipid nanoparticles.
Akanda MH; Rai R; Slipper IJ; Chowdhry BZ; Lamprou D; Getti G; Douroumis D
Int J Pharm; 2015 Sep; 493(1-2):161-71. PubMed ID: 26200751
[TBL] [Abstract][Full Text] [Related]
13. Self-reporter shikonin-Act-loaded solid lipid nanoparticle: formulation, physicochemical characterization and geno/cytotoxicity evaluation.
Eskandani M; Nazemiyeh H
Eur J Pharm Sci; 2014 Aug; 59():49-57. PubMed ID: 24768857
[TBL] [Abstract][Full Text] [Related]
14. Effect of lipid matrix on repaglinide-loaded solid lipid nanoparticles for oral delivery.
Rawat MK; Jain A; Mishra A; Muthu MS; Singh S
Ther Deliv; 2010 Jul; 1(1):63-73. PubMed ID: 22816120
[TBL] [Abstract][Full Text] [Related]
15. The Anticancer Activity of Complex [Cu2(μ-(C6H5)2CHCOO)3(bipy)2)] (ClO4) -Solid Lipid Nanoparticles on MCF-7 Cells.
Kani I; Dikmen G; Eskiler GG; Cecener G; Tunca B; Egeli U
Curr Drug Deliv; 2016; 13(8):1339-1350. PubMed ID: 26750100
[TBL] [Abstract][Full Text] [Related]
16. Preformulation, Characterization, and
Algul D; Duman G; Ozdemir S; Acar ET; Yener G
J Cosmet Sci; 2018; 69(3):165-173. PubMed ID: 30052191
[TBL] [Abstract][Full Text] [Related]
17. Microwave-assisted formulation of solid lipid nanoparticles loaded with non-steroidal anti-inflammatory drugs.
Shah RM; Eldridge DS; Palombo EA; Harding IH
Int J Pharm; 2016 Dec; 515(1-2):543-554. PubMed ID: 27789371
[TBL] [Abstract][Full Text] [Related]
18. Preparation, characterization and in vitro cytotoxicity of paclitaxel-loaded sterically stabilized solid lipid nanoparticles.
Lee MK; Lim SJ; Kim CK
Biomaterials; 2007 Apr; 28(12):2137-46. PubMed ID: 17257668
[TBL] [Abstract][Full Text] [Related]
19. Folic acid functionalized long-circulating co-encapsulated docetaxel and curcumin solid lipid nanoparticles: In vitro evaluation, pharmacokinetic and biodistribution in rats.
Pawar H; Surapaneni SK; Tikoo K; Singh C; Burman R; Gill MS; Suresh S
Drug Deliv; 2016 May; 23(4):1453-68. PubMed ID: 26878325
[TBL] [Abstract][Full Text] [Related]
20. Formulation, optimization, and characterization of rifampicin-loaded solid lipid nanoparticles for the treatment of tuberculosis.
Chokshi NV; Khatri HN; Patel MM
Drug Dev Ind Pharm; 2018 Dec; 44(12):1975-1989. PubMed ID: 30058392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
